Sinopharm's biologics arm, developing and manufacturing vaccines, plasma products and diagnostics through a network of institutes and laboratories.
A Sinopharm research institute developing inactivated and recombinant vaccines, and host of China's national engineering centre for new vaccines.
1 model
National Vaccine and Serum Institute / China National Biotec Group
Released August 29, 2026
Protein stability predictor that fuses ESM-2 sequence embeddings into the ThermoMPNN structure network to score ΔΔG for single-point mutations.